Oral Presentations
Oral 1 - | Pulmonary Infection |
| Time | 09:00‑10:10 Monday 20th November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Naoto Keicho
Research Institute, International Medical Center of Japan, Japan
Glen Westall
Lung Transplant Unit, Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital Department of Medicine, Monash University, Melbourne, Australia |
| Presentation 1 | Comparison of three prediction rules for prognosis in Community Acquired Pneumonia; Pneumonia Severity Index (PSI), CURB65 and A-DROP Kazuhiro Usui
Division of Respirology and Chest Surgery, Kanto Medical Center, NTT-EC, Japan |
| Presentation 2 | Evaluation of Role of Endotracheal Secretion Culture in Diagnosis of VAP
Pratibha Gupta
Department of Chest Medicine, Sir Ganga Ram Hospital, New Delhi, India |
| Presentation 3 | A Validation and Potential Modification of Pneumonia Severity Index in the Elderly Community-Acquired Pneumonia
Tateaki Naito
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan |
| Presentation 4 | Expression of β-Lactamase in Pseudomonas Aeruginosa Biofilms
Handong Jiang
Department of Pulmonology, The Affiliated Hospital of Medical College, Qingdao University, Shandong, China |
| Presentation 5 | Dissecting the Impact of Cytomegalovirus Following Lung Transplantation
Glen P Westall
Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Department of Medicine, Monash University, Melbourne, Australia |
| Presentation 6 | Additive Effects of Pneumococcal Polysaccharide Vaccine in Combination with Influenza Vaccine on Acute Exacerbation in Patients with Chronic Lung Diseases
Akitsugu Furumoto
Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Japan |
| Presentation 7 | Pathological Findings in Avian Influenza For Autopsied Cases in the National Hospital of Pediatrics, Hanoi Koichiro Kudo
International Medical Center of Japan, Tokyo, Japan |
| Time | 10:10‑11:20 Monday 20th November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Eiji Shimizu
Tottori University, Medical Oncology and Molecular Respirology, Japan
Wah Kit Lam
University of Hong Kong, Hong Kong |
| Presentation 1 | Pharmacokinetics of Gefitinib Predicts the Antitumor Activity for Advanced Non-small Cell Lung Cancer (NSCLC) Minoru Fukuda
Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan |
| Presentation 2 | Genetic Variations of Systemic Superoxide Dismutase and Catalase Activities in Non-small Cell Lung Cancer James C. Ho
Department of Medicine, The University of Hong Kong, Hong Kong |
| Presentation 3 | Analysis of DNA Methylation of Tumor Suppressor Gene Promoters in Non-small Cell Lung Cancer Patients using Bronchoscopic Microsampling Hiroyuki Yasuda
Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan |
| Presentation 4 | Secondary T790M Mutation Conferring Shorter Progression-free Survival of Non-small-cell Lung Cancer Patients with Tumor Responsive to Gefitinib Jin-Yuan Shih
Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan |
| Presentation 5 | Feasibility of Virtual Bronchoscopic Navigation System for Peripheral Pulmonary Lesions Masahiro Ohsige
St. Mary's Hospital, International Health Center, Kurume, Japan |
| Presentation 6 | Radio Frequency Ablation Therapy in Non-small Cell Lung Cancer: State of the Art Issues and Practical Experiences in Bangladesh M Rashidul Hassan
Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan |
Oral 3 - | Pulmonary Tuberculosis |
| Time | 15:20‑16:10 Monday 20th November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Ikushi Onozaki
The Research Institute of Tuberculosis Japan Anti-Tuberculosis Association, Japan
Thomas Mok
President of Hong Kong Thoracic Society Ltd., China |
| Presentation 1 | Role of Cough Officer Screening in Early Detection for Pulmonary Tuberculosis in Inpatients
Lin Ching Hsiung
Chest division, Internal Medicine Department, Changhua Christian Hospital, Taiwan |
| Presentation 2 | In Cases Where Sputum Smear is Negative the Diagnostic Value of Gastric Lavage and Bronchoscopic Lavage Bahadir T. Uskul
Sureyyapasa Training and Research Hospital for Chest Diseases and Thoracic Surgery, Istanbul, Turkey |
| Presentation 3 | Diagnosis of Tuberculous Pleuritis by Antigen Specific Interferon-γ Response of Pleural Fluid Cells Haruyuki Ariga
Department of Respiratory Desease, Tokyo National Hospital, National Hospital Organization, Japan / The First Department of Internal Medicine, Kyorin University School of Medicine, Japan |
| Presentation 4 | The Enhanced Gen-probe Amplified Mycobacterium Tuberculosis Direct Test Versus Amplicor in Induced Sputum for the Rapid Diagnosis of Pulmonary Tuberculosis
T.K. Lim
Department of Medicine, National University Hospital, Singapore |
| Presentation 5 | Clinical Characteristics of Patients with Lung Tuberculosis Caused by Beijing and Non-Beijing Genotypes Prayudi Santoso
Subdivision of Pulmonology, Department of Internal Medicine, Padjadjaran University / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia |
Oral 4 - | RCMB - Respiratory Cell & Molecular Biology |
| Time | 16:10‑17:20 Monday 20th November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Takahide Nagase
University of Tokyo, Department of Respiratory Medicine, Japan
Paul N Reynolds
Department of Thoracic Medicine, Royal Adelaide Hospital Chest Clinic, Australia |
| Presentation 1 | GP130-STAT3 Signalling Enhances Bleomycin Induced Lung Fibrosis Independent of SMAD3 Signalling Robert J.J. O'Donoghue
Asthma and Allergy Research Institute, University of Western Asutralia, Perth, Australia |
| Presentation 2 | The Molecular Mechanism of Human β-defensin Cytotoxic Effects on Mammalian Cells Yasuhiro Yamaguchi
Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Japan |
| Presentation 3 | Neuropeptide Y (NPY) and NPY Receptor Expression in Human Monocyte-Derived Dendritic Cells (hMo-DC) Kendle M. Estcourt
Asthma and Allergy Research Institute Inc., Perth, Australia |
| Presentation 4 | A Novel Role of Hepatocyte Growth Factor as an Immune-Regulator through Suppressing Dendritic Cell Function Katsuhide Okunishi
Pulmonary Division, Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Japan |
| Presentation 5 | Aging and Cigarette Smoking Alter Expression of Various Receptors Related to Apoptotic Cell Clearance in Alveolar Macrophages (AMs)
Yoko Ito
The First Department of Medicine, Hokkaido University, Sapporo, Japan |
| Presentation 6 | Genetic Scan for Transcriptome Expressed by Alveolar Macrophages in Sarcoidosis
Etsuro Yamaguchi
Division of Respiratory Medicine and Allergology, School of Medicine, Aichi Medical University, Nagakute, Japan |
| Presentation 7 | Transdifferentiation of Human and Rat Mesothelial Cells into Osteoblast-like Cells in vitro
Sally M. Lansley
Asthma and Allergy Research Institute, Australia |
Oral 5 - | Sleep Disordered Breathing and Respiratory Care |
| Time | 09:00‑10:10 Tuesday 21st November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Hirohisa Toga
Department of Respiratory Medicine, Kanazawa Medical University, Japan
Indira Gurubhagavatula
University of Pennsylvania Medical Center, USA |
| Presentation 1 | Sleep Apnea, Commercial Drivers and Fall-Asleep Crashes: Should Acceptance of Treatment Be Required for Employment? Indira Gurubhagavatula
Center for Sleep and Respiratory Neurobiology, Division of Sleep Medicine, Department of Medicine, University of Pennsylvania Medical Center, USA / Pulmonary and Critical Care Section, Philadelphia VA Medical Center, Philadelphia, USA |
| Presentation 2 | Elevated Acylated Ghrelin and Treatment in Obstructive Sleep Apnea Ken-ichi Takahashi
Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan |
| Presentation 3 | The Mechanism of Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension Jin Zhang
Pulmonary Medicine, Affiliated Hospital, Ningxia Medical College, Yinchuan, Ningxia, China |
| Presentation 4 | Plasma von Willebrand Factor and ADAMTS13 Activity in Patients with Obstructive Sleep Apnea Syndrome Noriko Koyama
The Second Department of Internal Medicine, Nara Medical University, Nara, Japan |
| Presentation 5 | Regional Approaches to Respiratory Diseases Problems on the Far East of Russia Victor P. Kolosov
Far Eastern Scientific Center of Physiology and Pathology of Respiration, Blagoveschensk, Russia |
| Presentation 6 | Long-term Survival and Action Programme for Improvement in Prognosis in HOT Patients Yasushi Inoue
Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan |
| Presentation 7 | Outcome of Non Invasive Ventilation on Unplanned Extubation in the Adult Intensive Care Unit William E. del Poso
Division of Pulmonary and Critical Care Medicine, The Philippine Heart Center, The Philippines |
Oral 6 - | Interstitial Lung Diseases & Pulmonary Circulation |
| Time | 10:10‑11:20 Tuesday 21st November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Arata Azuma
Pulmanary Medicine, Nippon Medical School, Japan
Dong Soon Kim
ASAN Medical Center - Ulsan University |
| Presentation 1 | Expression of Hepatoma-derived Growth Factor in Tissues and Bronchoalveolar Lavage Fluids Obtained from Patients with Interstitial Lung Disease Seiji Hayashi
Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan |
| Presentation 2 | Clinical Analysis of 25 Cases with Biopsy-proven Cryptogenic Organizing Pneumonia Hui-Ping Li
Department of Respiratory Diseases, Tongji University affiliated Shanghai Pulmonary Hospital, Shanghai, China |
| Presentation 3 | Incidence of Pulmonary Hypertension and Its Clinical Relevance In Patients with Idiopathic and Collagen Vascular Disease Associated Interstitial Pneumonias Tomohiro Handa
The Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan |
| Presentation 4 | Clinical Characterization and Genetic Background in Familial Interstitial Pneumonia Yasuhiro Setoguchi
Division of Respiratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan |
| Presentation 5 | Prevention of Radiation-induced Pneumonitis by Recombinant Adenovirus-mediated Transferring of Soluble TGF-β Type II Receptor Gene Koichi Takayama
Research Institute for Diseases of the Chest, Kyushu University, Fukuoka, Japan |
| Presentation 6 | Role of Angiogenic Factors in Abnormal Vascularization of Bronchiectasis Veronica L. Chan
Division of Respiratory Medicine, Department of Medicine & Geriatrics, United Christian Hospital, Hong Kong |
| Presentation 7 | Pre-test Probability Scores in the Assessment of Pulmonary Embolism Liu Jia Lin
Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University, China |
Oral 7 - | Bronchial Asthma & COPD I |
| Time | 13:40‑14:50 Tuesday 21st November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Shu Hashimoto
Division of Repiratory Medicine, Department of Internal Medicine, Nihon University of Medicine, Japan
Monica Kraft
Duke Asthma, Allergy and Airway Center, Duke University Medical Center, USA |
| Presentation 1 | Anti-inflammatory Effects of Glycogen Synthase Kinase-3β Inhibitor in A Mouse Asthma Model W. S. Fred Wong
Department of Pharmacology, Yoo Loo Lin School of Medicine and Immunology Program, National University of Singapore, Singapore |
| Presentation 2 | Macrolide Attenuates Mucus Hypersecretion of Rat Bronchial Epithelia Through Inactivation of NF-kappa B Fu-Qiang Wen
Department of Respiratory Medicine, West China Hospital of Sichuan University, China |
| Presentation 3 | Decreased Nrf2 Expression in Peripheral Lungs of Smokers with Chronic Obstructive Pulmonary Disease (COPD) Masaru Suzuki
First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan |
| Presentation 4 | A Potent Anti-angiogenic Factor, Endostatin Prevents the Development of Asthma in a Murine Model
Yasue Suzaki
The Second Department of Internal Medicine, Nara Medical University, Nara, Japan |
| Presentation 5 | Constitutive, but not Transient, Overproduction of Interleukin-18 in the Lungs Results in Emphysema: A New COPD Mouse Model Tomoaki Hoshino
First Department of Internal Medicine, University of Kurume, Fukuoka, Japan |
| Presentation 6 | The Effect of in vivo Fluticasone on ex vivo Rhinovirus Induced Inflammation in Alveolar Macrophages from Asthmatic Subjects Brian G. Oliver
Department of Pharmacology, The University of Sydney, Sydney, Australia |
| Presentation 7 | Cytokine Expression in Exhaled Breath Condensate Measured by Protein Array: Correlation with Physiological Properties in Asthmatic Patients Kazuto Matsunaga
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Wakayama, Japan |
Oral 8 - | Bronchial Asthma & COPD II |
| Time | 14:50‑15:50 Tuesday 21st November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Atsushi Nagai
Tokyo Women's Medical University, First Department of Medicine, Japan
Parameswaran Nair
Department of Medicine, Division of Respirology, McMaster University, Hamilton, Ontario, Canada |
| Presentation 1 | Circulating Adioponectin in Patients with Chronic Obstructive Pulmonary Disease Koichi Tomoda
The Second Department of Internal Medicine, Nara Medical University, Nara, Japan |
| Presentation 2 | Induced Sputum in Asthma: Patient's Characteristics Associated with Successful Induction Hirofumi Matsuoka
Respiratory Medicine, Kyoto University, Kyoto, Japan |
| Presentation 3 | Phenotyping of Chronic Obstructive Pulmonary Disease Based Upon Computed Tomography Findings Masaru Hasegawa
First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan |
| Presentation 4 | Survey of Asthma Insights and Control in Pakistan (AIRIP) Paul W. Jones
Respiratory Medicine, St George's, University of London, UK |
| Presentation 5 | Trends in COPD Mortality in the Asia Pacific (AP) Region Wan C. Tan
iCAPTURE Centre, University of British Columbia, St. Paul's Hospital, Canada |
| Presentation 6 | Use of Sputum Cell Counts to Individualize Therapy of Airway Diseases Parameswaran Nair
Associate Professor of Medicine, McMaster University, Hamilton, Ontario, Canada |
Oral 9 - | Bronchial Asthma & COPD III |
| Time | 15:50‑16:50 Tuesday 21st November |
| Venue | Room C‑1 (seating capacity: 100) |
| Chairs | Keishi Kubo
Department of Medicine, Shinshu University Medical School, Matsumoto, Japan
Richard Li-Cher Loh
International Medical University, Kuala Lumpur, Malaysia |
| Presentation 1 | Effects of Salmeterol in Patients with Persistent Asthma Receiving Inhaled Corticosteroid Plus Theophylline Hiromasa Inoue
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan |
| Presentation 2 | The TOwards a Revolution in COPD Health (TORCH) Study: Salmeterol/Fluticasone Propionate Reduces the Rate of Exacerbations over Three Years Bartolome Celli
St Elizabeth's Medical Center, Boston, USA |
| Presentation 3 | Improved Asthma Symptoms and PEFR in Moderate Persistant Asthma Patients with GERD. The Role of Proton Pump Inhibitor Agus Dwi Susanto
Department of Respiratory Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia |
| Presentation 4 | Is GERD Related to COPD? The Potential Role of Chronic Mucus Hypersecretion Zhenying Cao
Department of Geriatrics, Rui Jin Hospital affiliated to Medical College of Shanghai Jiaotong University, Shanghai, China |
| Presentation 5 | Is Compliance with ICS Treatment Increased when a MDI Canister with Audible and Visual Reminder Functions is Used? Thomas Charles
P3 Research, Wellington, New Zealand |
| Presentation 6 | The Impact of Management Programs on Clinical Outcomes in COPD T. K. Lim
Department of Medicine, National University Hospital, Singapore |
(Note: These are not public sessions. Attendance is reserved for those who have
registered for the APSR2006 Congress.)
|
